The reduction of intratumoral Tregs improved the CD8+ Teff-to-Tregs ratio at the tumor site (Fig. 6G) and substantially augmented the prevalence of multifunctional CD8+ T cells at the tumor site (Fig. 6, H to J). Here, CD8A is linked to neoplasm.